| NCT07016750 | A Study Assessing KB803 Compared to Matching Placebo for the Treatment and Prevention of Corneal Abrasions in Dystrophic Epidermolysis Bullosa | RECRUITING | PHASE3 | 2025-06-20 | 2026-03 | 2026-03 |
| NCT06999733 | A Study Assessing KB801 for the Treatment of Stage 2 or 3 Neurotrophic Keratitis | RECRUITING | PHASE1, PHASE2 | 2025-05 | 2026-10 | 2025-12 |
| NCT06724900 | A Study Assessing KB304 for the Treatment of Wrinkles in Women | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2024-11-20 | 2025-08 | 2025-07 |
| NCT06228326 | A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs | RECRUITING | PHASE1, PHASE2 | 2024-04-17 | 2028-02 | 2028-02 |
| NCT06049082 | A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency | RECRUITING | PHASE1 | 2024-02-15 | 2026-12 | 2025-12 |
| NCT05970497 | A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors | RECRUITING | PHASE1, PHASE2 | 2023-10-31 | 2027-07 | 2027-07 |
| NCT05504837 | A Study Assessing KB407 for the Treatment of Cystic Fibrosis | RECRUITING | PHASE1 | 2023-06-30 | 2026-01 | 2025-12 |
| NCT05735158 | Topical KB105 for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI) | UNKNOWN | PHASE2 | 2023-03 | 2024-04 | 2024-03 |
| NCT05095246 | A Study of Inhaled KB407 for the Treatment of Cystic Fibrosis | WITHDRAWN | PHASE1 | 2022-03-08 | 2024-10-30 | 2024-07-01 |
| NCT04917874 | A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa | COMPLETED | PHASE3 | 2021-05-25 | 2023-07-31 | 2023-07-31 |
| NCT04540900 | A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions | ACTIVE_NOT_RECRUITING | PHASE1 | 2020-10-07 | 2029-05-31 | 2024-10-16 |
| NCT04491604 | Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB | COMPLETED | PHASE3 | 2020-08-17 | 2022-01-14 | 2021-10-29 |
| NCT04047732 | Topical KB105 Gene Therapy for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI) | UNKNOWN | PHASE1, PHASE2 | 2019-08-27 | 2025-03 | 2022-10 |
| NCT03536143 | A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients | COMPLETED | PHASE1, PHASE2 | 2018-05-06 | 2019-11-01 | 2019-11-01 |